NN-4103

N/A

Report date: 2025/03/13 16:56:02

First In Class

Base Information

Drug NameNN-4103

Drug Alias NameNN-4103

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionStem cell growth factor receptor inhibitors

TargetsStem cell growth factor receptor

Therapy Area/IndicationsGeographic Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovelty Nobility Inc

China Registration ClassN/A

Develop Information

Active CompaniesGC Biopharma Corp Novelty Nobility Inc

Inactive CompaniesN/A

Active IndicationsGeographic Atrophy

Inactive IndicationsN/A

Other Information

ATC CodeN/A